The Thin Line
Over the next five years, millions of more Americans are expected to take Ozempic and other GLP-1 weight-loss drugs, which are rapidly being recognized as the miracle drugs of this century. If you’re not on them, you’ll probably know someone who is. What are the implications of the widespread use of these drugs, both on our bodies and our society?
In this show, you’ll meet people across America who are either taking the jab or thinking about it, and the shocking intentional and unintentional results they are seeing. The Thin Line looks at the promise and the peril of GLP-1s today, and explores what will happen in the near future with the democratization of these breakthrough drugs.
What is Ozempic?
Ozempic (semaglutide) is a prescription drug that helps the body produce insulin, lower blood sugar, and slow digestion. It's used to treat type 2 diabetes, but it can also lead to weight loss.
The Rapid Rise of Ozempic
The rapid rise of Ozempic has been fueled by social media buzz and endorsements from high-profile figures, creating a surge in demand. As a result, Ozempic has faced shortages, and its rising popularity has sparked debates about ethics, accessibility, and the implications of using a diabetes drug for cosmetic weight loss.
Dr. Lara Devgan’s Contribution
In Episode 6 of The Thin Line, Dr. Lara Devgan is brought on the show to offer her professional medical advice on the Ozempic trend in our society.
“The growing use of GLP-1 medications has led to a noticeable increase in the demand for both surgical and nonsurgical plastic surgery procedures, as patients seek to address changes in their appearance,” Devgan states.
Find us on instagram
